US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist

28.190
+1.070+3.95%

Close Jan 2 16:00 ET

28.610
+0.420+1.49%

Post 20:01 ET

1.61BMarket Cap-14.60P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Structure Therapeutics Earnings Reports

Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 22:32 ET

Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

Nov 13, 2024 16:17 ET

Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:40 ET

Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

Aug 8, 2024 16:21 ET

Analyst Rating

Updated: Jan 2, 2025

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall